This ADC product is comprised of an anti-CD74 monoclonal antibody (011(B)) conjugated via a VC linker to MMAE. The MMAE is targeted to Daudi-luc tumors by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cel
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten